Overview
As Director, you lead end-to-end Early Stage pharma transactions from structuring to signature, partnering with cross-functional teams to advance our Human Health portfolio. You shape deal economics, governance, and negotiation strategy for European collaborations, licenses, options, and potential acquisitions. You’ll drive high-impact negotiations and ensure smooth handover to implementation teams, with exposure to strategic Commercial deals in Europe. This role combines leadership, deal-making, and scientific fluency in a fast-paced, high-impact environment.
Responsibilities
- Own end-to-end transaction process from term sheet to contract signature.
- Develop deal structures, scope, ownership, and financial terms to support negotiation strategy.
- Lead internal deal governance and stakeholder alignment to enable timely sign-off.
- Interface with Search & Evaluation, Commercial, Manufacturing/Supply Chain, Legal and Patents, and Alliance Management.
- Collaborate with cross-functional teams to solve complex problems and drive handover to implementation.
Key requirements
- Substantial experience in pharmaceutical business development with ownership of deal workstreams.
- Hands-on experience leading Early Stage transactions and familiarity with market benchmarks.
- Strong knowledge of common structures used in Early Stage transactions.
- Excellent deal execution, negotiation strategy, and contracting process management.
- Ability to influence executive leadership and align diverse stakeholders for timely decisions.
- Lead and influence cross-functional teams under pressure
- Structured problem-solving and option development
- Clear, concise communication with executives
- Deal Strategy
- Negotiation
- Project Management Leadership
…
